Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in AdultsDick Menzies, Andrea Benedetti, Mênonli Adjobimey et al.|New England Journal of Medicine|2018Cited by 392
Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trialMüge Çevik, Borisov Se, Mookho Malahleha et al.|The Lancet Infectious Diseases|2024Cited by 60